Celltrion Healthcare IPO Set To Benefit From Biosimilar Successes

Amid Celltrion's string of biosimilar approvals and launches in the US and Europe, its marketing and distribution arm Celltrion Healthcare seems to have picked the perfect timing to launch an IPO.

US dollars

For investors in Celltrion Healthcare, the long wait seems to have been worth it.

After initially planning an initial public offering a few years ago, Celltrion Healthcare, the exclusive marketing, distribution and partnering arm...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia